[Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride].
D002118:Calcium / Q000627:therapeutic use; D002124:Calcium Fluoride / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005081:Exercise Therapy; D005457:Fluoridation; D005459:Fluorides / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced; D010434:Pepsin A / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000627:therapeutic use*; D014807:Vitamin D / Q000627:therapeutic use
D014807:Vitamin D; D012969:Sodium Fluoride; D010434:Pepsin A; D002124:Calcium Fluoride; D005459:Fluorides; D002118:Calcium
Probleme der Natriumfluorid-Hochdosistherapie bei Osteoporose. 3. Mitteilung: Praxis der Osteoporosetherapie mit Natriumfluorid.